Products

Intravenous Immune Globulin Products

Immune globulin is made from pooled plasma collected from thousands of donors and treated to remove contaminants to ensure product safety and integrity. Containing antibodies against a broad spectrum of bacteria and viruses, IVIG is administered intravenously and is used primarily to treat three categories of illnesses: immune deficiencies, autoimmune neuromuscular disorders and certain neurological disorders.

NuFACTOR carries the following F.D.A.-approved immune globulin products:

* denotes that NuFACTOR does not currently carry this product.


Product
Manufacturer
FDA-Approved Indication
INTRAVENOUS IMMUNE GLOBULIN (IVIG)
Product: Carimune® NF
Manufacturer: CSL Behring
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD), Immune Thrombocytopenic Purpura (ITP)
Product: Flebogamma® DIF 5%
Manufacturer: Grifols
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: Flebogamma® DIF 10%
Manufacturer: Grifols
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: GAMMAGARD S/D
Manufacturer: Shire
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD), Chronic Lymphocytic Leukemia (CLL), Immune Thrombocytopenic Purpura (ITP), Kawasaki Disease
Product: GAMMAGARD S/D (IGA<1 MCG/ML)
Manufacturer: Shire
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD), Chronic Lymphocytic Leukemia (CLL), Immune Thrombocytopenic Purpura (ITP), Kawasaki Disease
Product: GAMMAGARD LIQUID
Manufacturer: Shire
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: GAMMAKED
Manufacturer: Kedrion
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP), Immune Thrombocytopenic Purpura (ITP)
Product: Gammaplex® 5%
Manufacturer: Bio Products Laboratory
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: Gammaplex® 10%
Manufacturer: Bio Products Laboratory
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: Gamunex®-C
Manufacturer: Grifols
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD), Immune Thrombocytopenic Purpura (ITP), Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Product: Octagam® 5%
Manufacturer: Octapharma
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: Octagam® 10%
Manufacturer: Octapharma
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD)
Product: Privigen®
Manufacturer: CSL Behring
FDA-Approved Indication: Primary Immunodeficiency Diseases (PIDD) Immune Thrombocytopenic Purpura (ITP)
Click here for patient admission documents.